Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Treatment of astrocytes with morphine decreases expression of neuroinflammatory genes. by Kenneth Chen (8622645)

TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

FTY720 treatment decreases SIV infection in blood and in LN Tfh cells. by Maria Pino (109981)

Absolute CD4 T cell proliferation and plasma IL-7 levels are decreased in treated HIV infection. by Charline Bacchus-Souffan (10005048)

Depletion of NUP proteins decreases MLV infection of DCs but not NIH3T3 cells. by Karen Salas-Briceno (10934215)

Pharmacokinetic-pharmacodynamic (PK-PD) viral dynamic model in which efavirenz decreases the rate of infected host cells. by Nontiya Homkham (6707570)

Divergence from transmitted/founder (TF) virus increases during ART-naïve infection and decreases on treatment. by Kelsie Brooks (8928044)

CXCL10 production is enhanced in the setting of HIV and HBV co-infection in vitro and decreased with the addition of antiretroviral agents efavirenz or raltegravir. by Kasha P. Singh (9354307)

Distance from transmitted/founder (TF) virus decreases with subsequent sampling during treatment. by Kelsie Brooks (8928044)

CSF CCR5+ CD8 T cell frequencies do not decrease during acute SIV infection. by Sonny R. Elizaldi (9684796)

Knock-out of Super Elongation Complex members does not decrease HIV-1 infection in primary CD4+ T cells. by William J. Cisneros (19648566)

Siglec-9 blocking antibody decreases viral infectivity of the supernatants of co-cultures of NK and autologous HIV-infected primary CD4⁺ T cells. by Opeyemi S. Adeniji (11682034)

Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis. by Garett Dunsmore (11021169)

AXL antibody decreases ZIKV infection. by Fiorella Rossi (134126)

Table_2_Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons.xlsx by Katalin A. Wilkinson (10193231)

“…Our data indicate that ART-induced decrease in immune activation combined with improved antigen responsiveness may contribute to reduced susceptibility to tuberculosis in HIV-1/Mtb co-infected persons.…”

Average number of cumulative new HIV infections and mean number of averted HIV infections among African American women over 20-year period by scenario. by Joëlla W. Adams (2192254)

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …”

Cellular co-infection decreases the potential for superinfection. by Brigitte E. Martin (8366847)

Survival of infection decreases as initial dose increases. by Moria Cairns Chambers (7542080)